Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 3, 2009

NEW YORK (GenomeWeb News) - Qiang Zhang has been named director of the Hamner Center for Dose Response Modeling at the Hamner Institutes for Health Sciences. In this position, Zhang will lead the center's systems biology efforts to understand non-linear biological response networks and to develop computational methodologies for understanding cellular pathways and toxic response.

Zhang was a post-doctoral researcher at the Hamner Institute for Health Sciences from 2003 to 2006, and after that he was promoted to research investigator.


Christopher Ahlberg has joined Fina Technologies' board of directors. Ahlberg, a founder and former CEO of Spotfire, also serves on the board of directors at Apptus Technologies AB and the Hult International Business School. He also was executive VP of Tibco and president of Tibco's Spotfire division.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.